Skip to main content
. 2021 Aug 20;4(8):e2120951. doi: 10.1001/jamanetworkopen.2021.20951

Table 1. Demographic and Clinical Characteristics of Patients With Extremity Soft-Tissue Sarcoma in the National Cancer Database.

Characteristic Patients, No. (%) P valuea
Total (N = 8953) Age, y
18-39 (n = 1280) 40-64 (n = 3937) ≥65 (n = 3736)
Radiation
No RT 3106 (34.7) 521 (40.7) 1218 (30.9) 1367 (36.6) <.001
RT 5847 (65.3) 759 (59.3) 2719 (69.1) 2369 (63.4)
RT type
No RT 3106 (34.7) 521 (40.7) 1218 (30.9) 1367 (36.6) <.001
Preoperative RT 1801 (20.1) 235 (18.4) 891 (22.6) 675 (18.1)
Postoperative RT 4046 (45.2) 524 (40.9) 1828 (46.4) 1694 (45.3)
Chemotherapy
None 6689 (74.7) 739 (57.7) 2667 (67.7) 3283 (87.9) <.001
Given 2012 (22.5) 504 (39.4) 1161 (29.5) 347 (9.3)
Unknown 252 (2.8) 37 (2.9) 109 (2.8) 106 (2.8)
Treatment
Amputation 520 (5.8) 104 (8.1) 217 (5.5) 199 (5.3) <.001
LSS with or without RT 8433 (94.2) 1176 (91.9) 3720 (94.5) 3537 (94.7)
Sex
Male 4796 (53.6) 708 (55.3) 2239 (56.9) 1849 (49.5) <.001
Female 4157 (46.4) 572 (44.7) 1698 (43.1) 1887 (50.5)
Race/ethnicity
White Non-Hispanic 6615 (73.9) 780 (60.9) 2855 (72.5) 2980 (79.8) <.001
White Hispanic 557 (6.2) 166 (13.0) 260 (6.6) 131 (3.5)
Black 921 (10.3) 192 (15.0) 464 (11.8) 265 (7.1)
Other or unknownb 860 (9.6) 142 (11.1) 358 (9.1) 360 (9.6)
Insurance status
Not insured 375 (4.2) 125 (9.8) 229 (5.8) 21 (0.6) <.001
Private insurance 4355 (48.6) 873 (68.2) 3020 (76.7) 462 (12.4)
Medicaid 524 (5.9) 198 (15.5) 270 (6.9) 56 (1.5)
Medicare 3425 (38.3) 38 (3.0) 267 (6.8) 3120 (83.5)
Other or unknown 274 (3.1) 46 (3.6) 151 (3.8) 77 (2.1)
Median income in patient’s zip code in 2012, $
<38 000 1460 (16.3) 233 (18.2) 657 (16.7) 570 (15.3) .009
38 000-$47 999 2033 (22.7) 278 (21.7) 873 (22.2) 882 (23.6)
48 000-$62 999 2369 (26.5) 347 (27.1) 984 (25.0) 1038 (27.8)
≥63 000 2949 (32.9) 405 (31.6) 1361 (34.6) 1183 (31.7)
Unknown 142 (1.6) 17 (1.3) 62 (1.6) 63 (1.7)
Non–high school graduates, % of population in patient’s zip code
≥21 1466 (16.4) 251 (19.6) 694 (17.6) 521 (13.9) <.001
13-20.9 2140 (23.9) 300 (23.4) 903 (22.9) 937 (25.1)
7-12.9 2911 (32.5) 419 (32.7) 1260 (32.0) 1232 (33.0)
<7 2308 (25.8) 296 (23.1) 1027 (26.1) 985 (26.4)
Unknown 128 (1.4) 14 (1.1) 53 (1.3) 61 (1.6)
Living location
Metropolitanc 4500 (50.3) 668 (52.2) 2055 (52.2) 1777 (47.6) <.001
Smaller metropolitanc 2699 (30.1) 397 (31.0) 1125 (28.6) 1177 (31.5)
Urban 1289 (14.4) 164 (12.8) 558 (14.2) 567 (15.2)
Rural 139 (1.6) 11 (0.9) 64 (1.6) 64 (1.7)
Unknown 326 (3.6) 40 (3.1) 135 (3.4) 151 (4.0)
Distance to reporting facility, miles
≤10 3145 (35.1) 404 (31.6) 1357 (34.5) 1384 (37.0) .004
11-20 1652 (18.5) 250 (19.5) 758 (19.3) 644 (17.2)
21-50 1798 (20.1) 258 (20.2) 815 (20.7) 725 (19.4)
>50 2232 (24.9) 355 (27.7) 952 (24.2) 925 (24.8)
Unknown 126 (1.4) 13 (1.0) 55 (1.4) 58 (1.6)
Comorbidity, No.
0 7360 (82.2) 1214 (94.8) 3374 (85.7) 2772 (74.2) <.001
1 1303 (14.6) 61 (4.8) 471 (12.0) 771 (20.6)
2 290 (3.2) 5 (0.4) 92 (2.3) 193 (5.2)
Transition in care
No 1358 (15.2) 212 (16.6) 571 (14.5) 575 (15.4) <.001
Yes 4851 (54.2) 683 (53.4) 2174 (55.2) 1994 (53.4)
Unknown 2744 (30.6) 385 (30.1) 1192 (30.3) 1167 (31.2)
Primary site
Upper limb 2188 (24.4) 338 (26.4) 878 (22.3) 972 (26.0) <.001
Lower limb 6765 (75.6) 942 (73.6) 3059 (77.7) 2764 (74.0)
Grade
MD 1125 (12.6) 229 (17.9) 519 (13.2) 377 (10.1) <.001
PD 4698 (52.5) 666 (52.0) 2037 (51.7) 1995 (53.4)
UD 3130 (35.0) 385 (30.1) 1381 (35.1) 1364 (36.5)
Tumor size, cm
≤5.00 2610 (29.2) 409 (32.0) 1117 (28.4) 1084 (29.0) <.001
5.01-10.00 3288 (36.7) 480 (37.5) 1392 (35.4) 1416 (37.9)
10.01-15.00 1690 (18.9) 240 (18.8) 774 (19.7) 676 (18.1)
>15.00 1365 (15.2) 151 (11.8) 654 (16.6) 560 (15.0)
Clinical tumor stage
I 1935 (21.6) 301 (23.5) 824 (20.9) 810 (21.7) .34
II 4978 (55.6) 704 (55.0) 2210 (56.1) 2064 (55.2)
Unknown 2040 (22.8) 275 (21.5) 903 (22.9) 862 (23.1)
Depth of extension
Superficial 2324 (26.0) 301 (23.5) 956 (24.3) 1067 (28.6) <.001
Deep 5873 (65.6) 850 (66.4) 2657 (67.5) 2366 (63.3)

Abbreviations: LSS, limb-sparing surgery; MD, moderately differentiated; PD, poorly differentiated; RT, radiation therapy; UD, undifferentiated.

a

P value derived from χ2 test.

b

Other races/ethnicities included American Indian, Aleutian, or Eskimo; Chinese; Japanese; Filipino; Hawaiian; Korean; Vietnamese; Laotian; Hmong; Kampuchean; Thai; Asian Indian or Pakistani, not otherwise specified; Asian Indian; Pakistani; Micronesian, not otherwise specified; Chamorran; Guamanian, not otherwise specified; Polynesian, not otherwise specified; Tahitian, Samoan, Tongan, Melanesian, not otherwise specified; Fiji Islander; New Guinean; other Asian, including Asian, not otherwise specified, and Oriental, not otherwise specified; and Pacific Islander, not otherwise specified.

c

Metropolitan was defined as having a population of 250 000 or greater; smaller metropolitan, 20 000 to less than 250 000.